Malarone Pediatric Interactions
There are 123 drugs known to interact with Malarone Pediatric (atovaquone/proguanil), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 13 are major, 103 are moderate, and 7 are minor.
- View all 123 medications that may interact with Malarone Pediatric
- View Malarone Pediatric alcohol/food interactions (1)
- View Malarone Pediatric disease interactions (4)
Most frequently checked interactions
View interaction reports for Malarone Pediatric (atovaquone / proguanil) and the medicines listed below.
- Betadine (povidone iodine topical)
- calcium carbonate
- chloroquine
- cholera vaccine, live
- clarithromycin
- Claritin (loratadine)
- desloratadine
- disulfiram
- doxycycline
- fluoxetine
- folic acid
- glutathione
- hydroxyzine
- magnesium citrate
- Mepron (atovaquone)
- methylphenidate
- montelukast
- multivitamin with minerals
- naltrexone
- nystatin
- phenazopyridine
- primaquine
- Quercetin (bioflavonoids)
- serrapeptase
- Synthroid (levothyroxine)
- Tamiflu (oseltamivir)
- typhoid vaccine, live
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- yellow fever vaccine
Malarone Pediatric alcohol/food interactions
There is 1 alcohol/food interaction with Malarone Pediatric (atovaquone / proguanil).
Malarone Pediatric disease interactions
There are 4 disease interactions with Malarone Pediatric (atovaquone / proguanil) which include:
Report options
More about Malarone Pediatric (atovaquone / proguanil)
- Malarone Pediatric consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antimalarial combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
